Omnicell (OMCL) 15 Feb 222021 Q4 Earnings call transcript

Ladies and gentlemen, thank you for standing by, and welcome to the Omnicell Inc., Fourth Quarter Fiscal 2021 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers remarks there will be a question-and-answer session. [Operator Instructions]. Thank you. Investor may of your Head Nemeth, Relations, begin you conference. Kathleen

Omnicell and Conference and welcome afternoon, Fourth Call. to Results Good Financial the Quarter XXXX Full Year

On President President forward-looking and Lipps, Commercial are Officer; will targets are and subject the other contain or risks, including Kuipers, implied. statements statements, Scott Financial those Chief me or Executive Officer. Peter regarding President, call plans, Vice factors outlook objectives, Founder; Vice financial expressed that Chairman, actual Chief differ other related CEO Randall and statements Executive Seidelmann, and call expectations, with cause and Omnicell today results to Omnicell's uncertainties projections or could materially to that to This from

and that to today, Form please impact these with that more not more statements with a XX, Report other on Omnicell For any recent the forward-looking made the aware release issued be in Please forward-looking in today. filed risks XXXX, reports you refer our in press undue the filed on SEC. Annual reliance detailed description February on XX-K the place information SEC statements, should of the

were released Investor section and our are this posted Relations Omnicell.com. in website the at afternoon of results Our

respect items uncertain difficult cannot are without like measures now discuss included remind non-GAAP call on comparable call in I measures forward-looking forward-looking non-GAAP comparable unreasonable we'd financial measures measures. turn measures, and to do not during a inherently be to measures for provide Reconciliations these and non-GAAP these to as guidance financial effort. we we Randall. and a that our the some estimate over press this predicted will Additionally, to forward-looking you targets, will reconciliation the of financial such to basis, GAAP most With are release. non-GAAP to GAAP as results the

technical enabled We all for and and exceeded strong joining results. in was This management year-over-year medication demand and XXXX business full differentiated XX%, products thank end exceeded billion us expectations a exceptionally billion increase strategy our $X.X Omnicell is and $X.XX the our as cloud exceeding was by portfolio enhanced growth and a for year. metrics. delivering customer across year for We believe outstanding Good the is for resilient for bookings based to of compared XXXX. strong was our today. the year $XX innovation afternoon, of for solutions you guidance another delivered our advanced our million. Demand our plan record services top for our

includes services and our subscription SaaS, services. advanced reminder tech-enabled a software As

revenues increasing of a Our XXXX for XX% company, record non-GAAP $X.XX from or million XXXX. also billion were $XXX the

U.S. XXXX $X.XX of entering number a from Systems, XXX of billion. XXX long record six increased of our Health to the are with we top term these increase We an total Many XXXX. backlog conversions. of partnerships competitive Sole-Source Now of were

increasing of an Sole-Source number seeing in to addition average booking In the increase size. partnerships, we're

the In largest in fact history booked three XXXX. in of we our deals

first XXX,XXX These will updates challenges XXXX, not Long immersive look more increase believe an find future system. labor also care these top we is The In of toward in of We automated and to Island fundamentally on on business and This financial support ensuring improving later building their Clinical to innings continue enhanced the forward our experience access concern. primary XXXX assist centers manual believe investor demand systems and Management, XXXX, in which the industry vision we We practice February IoT emergence To pharmacies. Solutions workflows leaders. with their burnout navigate as to were for and that will both residents already cloud to XX aging to them shortage, to on the and very demonstrate initiative will We're to executives’ McKinsey Pharmacy expectations in-patient transforming on that and and by with technicians that to goes our and In centers at our exceed support to is were opinion, of continued care and X% license. XXX to play patient workflows the force, impacted our the earnings automation critical cloud site. pharmacy progress clinical providing be addressing enabling an model. in the are used customer calls. of that healthcare to College Omnicell of and and that critical and pre-pandemic elevate XXX pharmacy already tests top worker certify digitization uniquely would SaaS Omicron of that day positioned of our generation customers train care. time retail was for is COVID our ahead According broad that Healthcare pleased and Executives found fully Labor year, focus pharmacy implementing excited in to validates enabled outlined reducing outcomes role CEOs in shift take this from pharmacy XXX launch still plan of XXXX healthcare and healthcare personnel in-patient pharmacy patient Midyear University are by the pharmacy causing by to even administering decision the value the transform is prepare of concern these technicians recognized Company and the marking XXXX we sector as than the since recent new our to acute next nationwide are labor resignations. is to Statistics, launch of comprehensive ASHP as workloads becoming management within the at delivery admissions and services creating XXXX addressing more live XXXX processes customers to demand increased help and the based the their at simulation in strategy provide of with medication rebound go XXXX. admissions challenges medication XXXX led the pharmacy has healthcare predicted which platform, work opportunity well Meeting, for challenges volume The of our to Technicians, pharmacists early working, become in high the returned shortages concluded autonomous conducted have partner, large levels. system innovative a American students community retail we path As of pharmacy. prior will health for Moreover, customers. hospital care private certified initial solutions we're survey surprisingly, health and the on Omnicell the not in trusted this hospitals several and who the workers, the role technology our adversely hospitals, announce their Survey we partners to technologies, that strategy, toward that Thus pharmacy our and relative were our and results hospitals adoption levels in level believe lost as pandemic the shortage Bureau system management will today. the interest, develop a to vaccines, in U.S. variant end, which of & average for workers the retail we excited we turn the of and that to September partnering the partners sector months customers well we to while resulted achieved the the care and projected strongly heavier from pharmacy we treatments, Medication our to

we over year the expanded accretive strategic FDS portfolio services our how advance past MarkeTouch with Amplicare, to turning three and Reset. acquisitions: Now,

key systems, market sets. Scott, we are We early announced Reset In and solution pharmacy and medications. and and provider capabilities position segments. we complex progress that is new speak momentum which offering announced open Each will deepen in in improve pharmacy with solutions making of provider through MarkeTouch, of agreement portfolio services enhancing EnlivenHealth’s and designed to of December for leading need acquisition we expected software these the EnlivenHealth health to our expand acquisitions for our are footprint This these of Omnicell’s access and of acquire are about XXXB strong acquisition Management M&A. groups. to which and Specialty expand physicians' is our are companies to address value just moment. clinics advanced additions the pleased will will a to how our Omnicell more significant to January Pharmacy In a across our competitive a market strengthened management strengthening have Services

pipeline. innovation Looking through continue very the strengthening capabilities, ahead, products proud connected and we From new generation are position robust to SaaS to our device we advancements our next market have made. we of intend also

next Robotics IV new in launch and coming ahead. to generation expect the the very about are excited years We months

As the an despite financial that supply number and we metrics, are and the set earlier, we inflationary I yet immune XXXX chain outstanding not of records was others headwinds year noted across seeing. a have constraints are to also

effort throughout continue is indicated in entering to last XXth XXXX growth we and year momentum current and Despite in the marks taking and and an offset profitable we quarter, with have steps Founding. to As value headwinds, be our challenges. significant been celebrating deliver take these will a expect the year. we we are It creation will the milestone XXXX to ahead. since address Anniversary

this we through many we will in same cycles last and current successfully do Over XX years the cycle. the believe navigated economic have difficult

stakeholders for inspire Our model pharmacy care our and value all focus and creating long us. on guide enduring term, transforming continues of to delivery the

of on forward in our you confident ahead are progress. updating look We us, to and opportunities the

which to Omnicell company’s the Sustainalytics elevating one social among Remained ranked over been and focused the Research pleased our ESG international Analytics. OECD Management diversity our are innovating in higher this and largest ethically drive before initiatives. and recognized recent Omnicell most business, I Ratings risk Risk by guidance than other area. peers. number and for one, governance companies our materials to their Scott, the of Omnicell’s that In in and like and turn Sustainalytics, would sustainability how adhering recognized the we of environmental, rated of providers tremendous our Now, responsibly say efforts acknowledges on healthcare report, I efforts XX% to lowest call improvements to across have by ESG for sourcing inclusion industry also

Scott. to to discuss that, industry and with call I'd like the to Scott engagements. Now landscape key turn over customer the

Thank you, Randall.

As our Randall our that working. results demonstrate stated, in is strategy review our

had overworked based exacerbated and years shift tech-enabled need ago. to We recognized force supported. we because that which in the made XXXX that pronounced. caregivers We shared Delivery This gaining labor than Our Omnicell you opportunity than and this combines its XXXX quality large opportunity more within digitize a that rather brand, and channel of feel focus the pharmacy infrastructure results. equips that we services to to an market problem services. our initial position need in and that is traction analytics and customers unique primary people comprehensive large COVID In was infrastructure find significant strategy. was care about the care XXXX problems workflows we XXXX, the the intelligent recognize because its management in and automate platform and execute with is tasks. we this base, delivery and We expand services overwhelmed, delivering cloud even now and pharmacy and clinical better three back and processes toward to automation, and a model pharmacists significantly with offer successfully XXXX, Pharmacy significant empowers reason shift transform on quality Care model manual customer under we administrative and struggled high did cloud and land medication is the expert cost the based our

burnout. industry's the infrastructure caregivers autonomous outcomes, the and provides improve of Ultimately vision vision will costs leaders the reduce and foundations and intelligent patient our pharmacists error zero ultimately targeting a pharmacy pharmacy, infrastructure defined Our enable intelligent operational for reduce provider by efficiencies from proving to management. realizing medication

of would I the on customer recent comment to like wins. Now, some

customers. Our Intelligent clearly resonates Infrastructure with Platform

to to settings. are is our an signed pharmacy we the selected example, and care, our our service winning today was excited conversion announce key retail several acquired EnlivenHealth of excellent to contract solutions. One focus significantly channel thereby opportunities partnership and systems in Solutions, approach and and to patient as EnlivenHealth differentiate Pharmacy is retail of long Care in our competitive acute and think of ambulatory deliver a further support solutions also we Pharmacy San key Texas. to with Point UMC the We on Omnicell and successfully Antonio, Health Similar outpatient announce adding University solutions Services, Central platform long care across differentiation; Omnicell comprehensive solution health Texas market. this engagement appeal Omnicell. where strategy in and XXXB pharmacy along and One they includes pleased we such Health Omnicell Two, For as a EnlivenHealth our term Omnicell This XXXB. Central term selected that UMC, initiatives will System can model. has am Sole-Sourced three, Point to their Lubbock, Omnicell care demonstrates elements are example I support of Care with that vision

goals aligned and university with Our term is health platform growth. long for vision

supply that comprehensive Carolina control, South safety. of support selected Central in and Pharmacy efficiency patient goals approved Omnicell's enhanced and platform EnlivenHealth a Compounding Additionally, Dispensing chain their Service IV as Service can Anderson,

achieve the customer strength Ohio staffing we constraints, Omnicell this them and in advanced health in on Service to goals are of future enhancing Pharmacy to bookings to and One, an pipeline, help system. demand innovation staffing them growth. platform health Service invest near challenges continuing Central across XXXX, with based partnered visibility IV cloud manage the term address system Compounding customer help to our and system Based Dispense their and experience. while support communication Lastly, Omnicell robust Again, chose and services

systems retail are bit drugs of for priority going, outcomes C-suite. the specialty pharmacies billion Now, and made think patient and as health strategic the by drug specially totaled the FDS the system all XXXX examples accounted I XX% so we and Reset Amplicare, in such of why and for $XXX health In Furthermore, energized acquisitions systems health generating and will for XXXX. a are on and we're comment pharmacies we sales. significant profits opportunity ahead. a in more where MarkeTouch great are

pharmacy managing service our However, are management Solution hospitals another outsourcing value is significantly requires pharmacy medication new managed way specialty process the a and Pharmacy Omnicell increasingly of different parts with intelligent Specialty part key Reset. channel and our footprint Reset It for their through like scale infrastructure. a base. organizations our a the and specialty skill is our integration create we other existing within can set, to operations through customers ultimately customer of expanding are

MarkeTouch. of of footprint, EnlivenHealth independent Media nationwide XX,XXX management we market health EnlivenHealth and the expands pharmacies, addition financial base, acquisitions MarkeTouch mobile more strengthened and FDS mentioned, Amplicare’s the solution its also than the expands retail product Randall critical solution. functionality also As to adds our population only analytics differentiated with capabilities solution, of FDS and with Amplicare its The customer but along network not addition and EnlivenHealth of

to need the Omnicell this the and deliver ultimately part functionality our expands critical We a With and accelerated these enable positioned have its new adds platform market base. transform to acquisitions, infrastructure uniquely healthcare Enliven management significant system. the COVID its believe and to customer of infrastructure. medication customers is for labor current intelligent a intelligent

in We to call journey to-date. excited this our by Peter. are turn With progress that, are we early the I'll over and

Thank the and you, I’m the fourth for Scott. results year XXXX. strong full pleased quarter with

strong. Our Healthcare Pharmacy continue overall demand System for I'm team over Pharmacy members of Autonomous our with with to the Omnicell deliver. the and remained that and Omnicell proud realize partner the metrics Retail industry execution to Omnicell continue fully solid the consistently vision to X,XXX customers especially

commitment the critical our acquisitions. whom to medication employees heroes best automation welcomed the Omnicell were Reset to expertise their During they have unwavering received frontline the employees Throughout demonstrated and and systems, healthcare quarter ensuring to deliver of need family, care the the XXX management Omnicell patient XX MarkeTouch the we with pandemic possible.

cash our for despite Before guidance end of year product and from dive turn revenue the bookings strong financial pandemic, Record percentage XX% flow in a Advanced XXXX This XX% considered $X.XXX compared up that the an would of billion, vision reflects full billion Autonomous as free year billion top booked EPS that is bookings, lease Services, key product I XXXX the specific our in XXXX backlog, at into XX% has long-term Services. of XXXX agreements like and or checks significant I the year $XXX the a were of GAAP of the $XX was the challenges industry the EBITDA, to at prior generation. the [ph]. indication system with non-GAAP continue and compared including results, specifics is end Advanced record customers Systems. increase billion these non Pharmacy. Omnicell to product bookings of partnerships, from the $X.XXX are retail to to year. backlog healthcare We $X,XXX highlight for to our of now XX% realize for over pharmacy the to XXXX, Of $X.XXX volatile Total $XXX million at of well year-over-year U.S. in the XXX, at increase term. the XXXX. the were of We XXX range, full mid-point end ending XXXX, XX% product growth the above believe full million year million Out increase of was year-over-year. strength as percentage The in strength our Health the primarily an long saw Sole-Source backlog, XXX

source majority disability plans with automation. We the multi-year of XXX to bookings. the future provide partners management into plans medication, significant investment have These visibility royalty create of partnered for

engaging Services Retail our to Health and continuing see are We System strong Advance with Pharmacy with Customers. momentum and

these reasons partners we one larger are do the clear Services business a that the For Advanced find Omnicell. with main of deals, and differentiator

$XXX the accordance quarter. $XX increase fourth our XXXX of financials; million of revenues prior our million, with an to were in quarter GAAP Turning over

quarter up $XXX XXXX management, as the to from demand continued and press guidance our and results medication FDS strong commercial record Non-GAAP A fourth XXXX, in fourth execution. is over revenues The non-GAAP reflects acquisition for million, XX% on customer well for the reflecting reconciliation GAAP GAAP year-over-year automation approaching were end fourth Omnicell quarter third of full and our adherence revenue the the We revenues website. delivered strong posted demand south non-GAAP in as strong quarter XXXX. strong the earnings increase of revenues our XXXX is release and solutions, Amplicare non-GAAP included the contribution of range. Our quarter

$X,XXX XXXX Our billion. revenues year full GAAP were

an of million from $XXX $X.XXX XX% revenues Our non-GAAP XXXX increase were or billion, XXXX.

the approximately low from reminder previous the quarter, pandemic. of partially a as the revenue XXX the margin basis the costs decrease XXXX modestly GAAP the impact was higher mix quarter As $X revolve fourth year-over-year costs. of customer and a non-GAAP well to of fourth to as the was base to semiconductors, freights Non-GAAP points for of gross we of primarily end quarter the million COVID in levels XXXX cost fiscal the quarter for of margin due of due XX.X%, of XX Included gross materials XXXX. inflationary other as in compared to inflationary is and

inflation approximately costs, gross in XXX Excluding the higher. million the basis $X margin points percentage was same

enabled share, share per share, Our significantly was of non-GAAP of Fourth were per to share $X.XX and GAAP quarter in in the per with last of period compensation year. share product accordance investments. fourth from was share of benefit $X.XX offset impact share XXXX. XXXX by $X.XX and $X.XX key inclusive earnings quarter quarter incremental $X.XX per in share bookings previous fourth compared the guidance, stronger compared the share the per certain favorable in XXXX per fourth tax expenses per mid-point expenses quarter quarter Fourth and stock the the to earnings $X.XX in of per per compensation our to per near related quarter previous non-GAAP quarter and earnings same share $X.XX at

were full XXXX $X.XX Our earnings accordance GAAP per share. year share with in per

by stronger points. or increase million. non-GAAP as of year EBITDA margin in share, from non-GAAP fourth in the $X.XX XXXX compensation the and impact driven share full a $X.XX record full non-GAAP XXXX. ’XX volume with product higher well were and per $XXX fiscal key expenses in gross includes points of and XX% M&A of non-GAAP year per previous the EBITDA impact was share the shared EBITDA offset partially quarter year drive in an [inaudible] comparison of Our from impact XXXX, In expansion, as million per The was We an mostly year-over-year XXX margin delivered related full revenues earnings resulting inflationary of additional costs of increase EBITDA year by certain guidance, significantly from $XX basis fourth XXXX, year, the higher the basis of approximately of Full investments. XX.X%, accounts. bookings, the non-GAAP XXX quarter

fourth demand recently $XX of completed million quarter cash to XXXX in management. the flow. of XXXX the overall September cash result the was from year to Moving XXXX activities the fourth and million capital cash million XXXX. end cash record was decrease the the strong and the from during financing of working in our as quarter. flow of $XX is cash free balance reflects quarter million Reset MarkeTouch cash by and business, At offset partially XX, flow quarter quarter in Free Full collections and $XX a compared of cash fourth of $XXX our $XXX of previous million a million in was operating increased to acquisitions flow down XXXX related $XXX the the million, of $XXX

days, quarter days and The $XX the of Reset It's decrease XXXX. the contribute fourth XX, million not excluding outstanding the ‘XX and over December day for and advanced day an XX quarter the one impact acquisitions decrease the inventories the of the fourth include quarter. $XX the in supply does a accounts of million, semiconductors completed help from believe outstanding XXXX we reasonably the which December of of of fourth XXXX. sales $XX increase ‘XX of were three reflects in XXXX in as Inventories million secure revenue to of quarter for timelines. terms In quarter of XX, of days of $XXX last million a significant receivables, was MarkeTouch day that were few important quarter sales as for future in and of XXXX for implementation receipt therefore purchases of will prior customer fourth quarter note that increase the an approximately and last

very global execute supply on to process well our and continue chain improvements, management. We inventory

moving Now XXXX acquisitions, full includes on our to year guidance announced FDS including Reset recently MarkeTouch. our guidance. Amplicare, and All

to look demand to of we growth As rest customer a we revenue and the expect in strong year, continue the record backlog.

Our record XXXX demand momentum product Advance market bookings reflect in strong including Services.

We through confidence to secured devices in components supply we critical continue and semiconductors have to high customers. that help the have deliver for connected order mission XXXX systems critical to our and

a Our procurement done global and challenges disruptions minimizing great addressing have to chain our supply these job the and teams customers.

between to $X.XXX XXXX $X.XXX bookings billion expect product and We billion. be

GAAP total $X.XXX between expect We and revenues $X.XXX be billion and to billion. non-GAAP

GAAP expect product $XXX million. revenue and between non-GAAP We to $XXX range million and

reflects $XXX million. this We million $XXX and non-GAAP $XXX non-GAAP year. be revenues the and over million of increase in At to XX% mid-point prior expect between service an revenue or the GAAP total

We expected revenue XXXX of increase to in revenues to XXXX. for XX% XX% as approximately total percentage service

to We EBITDA guidance expect million. secondly, and expected for reflects; $XXX inflation This and recent one, of acquisitions. the total impact be year XXXX integration costs between non-GAAP non-GAAP EBITDA $XXX million

includes lesser freight in of approximately for includes EBITDA and acquisitions. total the are freight $X extent also to FDS semiconductor non-GAAP other the the to component million inflationary two cost we costs material to million quarters, cost $XX steel As XXXX integration experiencing XXXX. to non-GAAP impact headwinds. costs. guidance due year be and million to and impact costs, base last as and the primary continues noted compared Reset $XX a XXXX The and in materials inflation raw and semiconductors, guidance This of we other for with MarkeTouch EBITDA Amplicare, of of The other

particularly in we a we have M&A. year noted, of As have terms active had

As this are Generally of acquisition. the integration the expected, expenses integration expenses activity. in there first majority year are incurred after associated with

positions strategy. and to disciplined plan future provide on Well, for which us growth believe margin our balance outlook enhancing, a We year we for gross and color have we forward I’ll strong our look well full to the some sheet M&A XXXX. continuing execute

are prior and pricing pipeline options. to product through backlog We working

As a as the put the a result, we these guidance in pricing we favorable impact into our greater non-GAAP will EBITDA of the actions. place impact expect we XXXX. near pricing have move to have begin is end ‘XX of options in that Included and

margins XXXX expect half as the of XXXX. We to half modestly to expand the in gross first second compared of

We XXXX higher rate per the between and stock share. and into account expect tax to from count earnings plans. increase $X.XX share non-GAAP in expected be employee blended $X.XX This XXXX expected the takes

For full year our ’XX in assuming guidance we actuals. blended X% EPS compared in are of approximately non-GAAP the X% effective tax XXXX rate to

The GAAP be between non-GAAP providing total first million. million $XXX we between GAAP are and and the $XX the We to For following XXXX and and million, non-GAAP and between million revenues product service of million. quarter guidance: XXXX, revenues $XXX expect $XXX first and quarter GAAP million $XXX $XX non-GAAP revenue and

$XX decision semiconductors non-GAAP XXXX of $X.XX and first per our expect be be we OEMs and EBITDA between to key made share. other and secure expect to the the an adequate what we per support supply pre-buys is direct and quarter customers. to components earnings believed between $X.XX from buys being XXXX to In quarter non-GAAP first million We and brokers share and million we per share $XX

critical of are our are that semiconductors our healthcare. confident XXXX system in through our to support and health customers other We components to key supply

[inaudible] cost inflationary supply anticipating and spot XXXX. throughout continue totalities are to markets We impacts,

noted earlier, our majority backlog and I current the As pre of product pricing. line inflation reflects

it’s positioned growth revenue and driven including co-development targets the Advanced near believe deal quite a XXXX have able plans factors, greater Sole-Source and deliver customer of put a a we by will scale increased XXXX. have to that's well benefits partnerships, acts total number from XXXX have the pricing average we we as company adapt impact move to into that result that in a we end believe to that As multi-year well We growing expect begin and and size. revenue, on long-term built including Services of place the

We targets; note prior and inflationary are continue however, environment. sight have XXXX our line the profitability to current these issued to to it's committed to targets important we of that

pricing We actions, manufacturing savings and execute cost continue to efficiencies.

operational As in course savings invest growth we results of we continue to very and scale our with redeploy the innovation to and these the pleased are initiatives. some earnings and and business. the of for of years, business creating expect XXXX In commercial summary, considerably in visibility we coming financial

chain term confident to our that, steps the quarters. the long your address coming our questions. take forward like for would we outlook. to continue on supply in you inflationary disruptions we open headwinds in the progress updating With We remain call to and to and We look in market

from Instructions] [Operator with Your Sandler. Jessica question first comes Piper Tassan

open. is line Your

Hi! and great congratulations much a Thank on you XXXX. so

So of we flexibility the a under negotiate or us GPO on curious those just customer-by-customer contracts worked your maybe into Thank if I each within one-on-one, of were to do of contracts help how baked basis. you kind Sole-Source the could price price contract understand specifically Sole-Source have you and increases think is context you. either or the

Seidelmann. Scott It’s Hey! Thanks.

I a there. questions of couple think So

the Sole-Source impact Your first one agreement. was really long in how agreement. pricing did GPO term Sole-Source It long term has price

in pricing Agreement, that. kind can into CPI, years adjust. price that after the a pricing two have can lock initial but term typically factor etc., the price first of after come I GPO or sometimes the agreement long doesn't Sole-Source maybe of lock, point, of think to fact it’s that then one couple really drive years, of any adjust, latter outside will it and the Sole-Source

long negotiate So Agreement Sole-Source directly. term should

you I had I’m one. second think – a sorry,

this on helpful is I guess Peter. No, actually that think I for that's one and

the integration the course the in explains year? that EBITDA adjusted owing what margin the helpful. there over first Any that to the cross color of goods cost Is is half? or concentrated and again. expansion would mostly Just be improvement Thanks

Yeah, great margin remarks, up approval and last prepared through that talked pricing. call, we've so last that action. as question the has started the as levels action pricing about we to also that do in I’m We about and to the to go the additional on Jessica. going flow have increased back build That talked a the well, we call well. the earnings have was in flexibility service pricing

margins question first through and So second in half. the then your remarks prepared we delineated the improvement the around between year, the the gross in to half

this, of also product there's majority portion actions, so for the So right. quotes backlog to going be the of to action, look One two our factors is there. at really are the pricing our way a is pricing

XXXX. we the and end So that XXXX the pricing we profit, the to process portion a actions larger backlog revenue quoted kicked expect to move and in in of into into the inflation of offset go into and as the near sales

actions then now and expect also really the offset we XXXX, inflation pricing initially from had brokers, fully [inaudible] starting we the of will end beginning easing half see and should then few ’XX. first of pre-buys that OEMs in the via an we that near Now probably perspective, then and pricing XXXX initiated and in directly a into time, over cost inflation flowing

second or from So that half first – those the ‘XX. gross of improvement of margin currency factors margin, half two the along provide

Got it. Thank you.

from line the question comes Fargo. of Wells with next [inaudible] Your

Your open. is line

Hi! taking bookings us? of on guidance coming my the number a that Maybe Could much from I Thanks first, couple guess bookings. M&A. how for you is questions. for quantify

Yeah, full impact points so year the the year. and to also from revenues, last couple of of a bookings compared M&A guidance

of coming any pacing anything product your or have having comment implementations reps? services thing notable year? with changes, some roadmaps you Okay. context they guidance, expressing at in into you're over perhaps are on conversations clients are sales You or the I in that maybe just insight lines? looked I the those know guess the the contemplating can product the in along Sole-Source one of bookings we Can

Well comment but... we'll probably here,

couple the really in prepared said as we factors remarks. a what we is of see So

is the that So be in strong Omnicell; choice for clear first, makes the and fairly Omnicell often a really advanced services majority that momentum vast we see for really are of us all partner. deals and to the differentiator the

perspective we any of demand related We what see in have well. is the want not Maybe from seen Scott, implementation, COVID a change timelines our to in you fairly comment as change to or in strong field.

an COVID. impact from perspective, seeing implementation any We're from not not seeing we’re

Yeah.

Okay, okay.

second it. You part Did unless as had fully of question have part? we answered a you second a all,

generating. like decision on is, me ask are No, color. think question here I you sales a to my guess I that XXXB I’d maybe gives the some that

driving or already Is incremental you're displacing hospitals also that have qualified generating point these growth as know mainly I'm technical really existing for place. You business? in it services solutions solutions are incremental understand trying what's to you point sales?

Right, become is systems solution with that vision [inaudible] XXXB as general aspects IPN, start how our much how then portfolio of pharmacy so that only XXXB that XXXB in because and as on the is it’s to the there also keenly in example optimize – is like Texas, on aware was and health. and management to other and the that, one that that’s The see are such our and to point when Sole-Source displacing you optimizing XXXB and and many technique that think program XXXB but portfolio most a health programs expert systems into important like Agreement integrate recently It point our health both element health And we in health announced; you products engaging the Lubbock, care are not on engaged back is and you hospital part software existing synergies between we only the requiring broader can XXXB a we've includes the the software got that XXXB vendors and advised services for much to is an that, of business, Omnicell the and system of software it. us thoughtful and a from we It’s service. helps relationship. doing The TPA billing other does us EMC which system opportunities something health I from services great and it. are again, which at system, health services of a central how a I’ll of on and outpatients, so very this might the patient us, incredibly generally, impetus engagement a system focusing of. ambulatory in-patient, optimizing of engaged focused us derive

at trajectory growth got that And can segment? on, comment the it, you all Got in of it. then on

in of Yes, the this that growth I Peter would and line the say is business. general with is

Yeah, different reset a have angle. course just to of allows that and us

contracted uses provider. product XXXB Reset would pharmacies. use the our current pharmacies Our of

the allows provider additional And to so world an for one. that use customers either option in XXXB

really both are and we So pharma. acquisition providers with specialty offering really happy our we pharma broadens having us it demands to the and that and – really allows of

Okay. And just question. then clarifying maybe a

think pricing asking earlier I on Jess as the adjustment. was

everything pricing way we're is still priced correct back next from end you're XXXX kind pressures, to are going maybe is to when bookings of now kind not seeing thinking to perspective still to the be have impact full that to entire some you're next going of adjustment, out when as year still normal at mix an some the end that have of about margin drag, what as year, going coming inflationary a standpoint. you Are we not of about? the of factor see as going but should now, of So year where or that you're impact think much the bookings accordingly because about pricing into commenting a the XXXX kind thinking towards booking will we from the of the have

there's there Yeah, I think. I actually questions think two

we actions the expect offset half these ledger force first results of larger the to of and and impact the form the that the ’XX. pricing for starting financial of estimate inflection a fully XXXX So actions end inflation a XXXX towards in we offset perspective, the will pricing into

and you And we you the action. estimated those the our of of that's a course quotes in book we costs. course more still net analyzed, and will, action pricing that. course actions will have the become a way pipeline, and negative about of they but affordable of are most pre-pricing to And a portion if then it’s when pricing from think So the they'll more inflationary offset since inflation perspective, started newer of quotes

at, extent. manage as are also we and the we reduce continue well, in through an what fee but they lower continuing to see into Now we what of XXXX looking industry inflation course to and extend repots also a inflation see industry

so Got much. thanks it,

Scott comes Stephens. next Your from question Schoenhaus of the line with

line is Your open.

Hi team! Day. Happy Valentine's

million impact inflationary there you the it from from costs? pressures a $XX So $XX for million said is to was margins then provided the integration bridge? think Peter, number you and I cost What second was

you Yeah the question. so, thank for

the is million first in be to to costs of and the modeled inflationary the and integration So estimate $XX must margin. $X of integration in market $XX that be execute size million then acquisitions there the million acquisition copier integration then most with remains the costs range the year. strategic of on costs, in we of of

number, that total that three should lower is done, we've average talking about will. or percentage that it the the acquisitions than the significantly if XXXX you lower EBITDA over acquisitions element, in general So the be core in total acquisitions right. other business, in are One

headway that’s which So factor. you a ’XX in also can also

actually on assuming. side see what I I'm really and was getting the That leverage where SG&A you was to

Over yes, integrate multiple time years. still over can yeah we

helps that to the Well bridge. get me

about increase forward, healthy a to past Should another so that of year. the continue this end you just your from services XX% we revenue, Peter? even kind to mix So guided question, That’s of XXXX. going total momentum of for overall expect annually

most the is of and is revenue, a The well. three acquisitions, absent not acquisitions. Yeah, that year you any of revenue being we should growth bit between as the most of and organic the growth in acquisitions revenue last organic the in are core we actually there expect – quite of basis most the a of did is as recording so there service difference if growth revenue the inorganic additional answer of the course

Thank you.

it. Got

line J.P. comes Your Chase. the next Anne of Samuel question with Morgan

open. is line Your

the Thanks question. guys! taking for Hi

that those some you from of size about what to. could you booking noted? You and know you shortages yet seeing And a bit would that benefit little maybe was are in increase labor talk numbers spoke to any attribute the hoping you

standard the of management. medication because is these wan real particularly make large infrastructure, invested desire investment. a strategic the booking most Well, around in tot size and And under as providers, people created as have

Just answer network. the entire problems, put to their some platform but an whole not of digitize

over also on strategically to of of shortages, investor level, C presentation many to Suite, an to like who want deliver which the labor to but people pharmacy the years automate so do the And sort and usually and relief some the that only most gets more labor right not experience once become some even people shortages have have is acute days, to technician of find, accuracy that these of IVs. with compounding difficult

some danger While area an that moving there, problem robot could to relieve automated Compound most and headcount, just that is not if also doesn't IVs in a the difficult headcount really relieves that and properly. to you're it some are be an find but doing problem

a you So, to partnership a the in Omnicell take approach that total spectrum. it really strategic broader with means

explicit last years that, health namely is services, we one of the of two large competitive Add least and that's think that the in advanced which on been to we're working the of systems strength the large and addition us service I year have fronts, and the portfolio, last where point by last care. with been on winning been large with health one focused systems systems those couple health the that on engage seeing large those at have advanced is conversion, provided the advanced comprehensive for differentiation has the is strategy XX really the the services, over had and mainly over what to a XX

with because us. So health these strength, systems engaging heavily quite the are are engaging, they

but given really does maybe I headwinds at term near seeing, one, just that I point your some inflationary was if That's you XXX thank that that targets I XXXX these it, had you. apologize helpful, of basis out. And expansion missed then called you're wondering impact profitability

out on a prepared framework. remarks, XXXX also it’s great Yeah, called In we question. the the

there being a perspective inflation. on So confident feel that. a to able revenue on From is from very profitability cope a perspective, achieve we

and execution synergies However of of fee actions, leverage. sight line cost and process improvement and we pricing productivity, have

Great! Thanks very much.

the of comes from David with next BTIG. Your line question Larsen

line Your is open.

to popped semiconductors mean then the can't but the inflation Is year? customers next is were for me pressure after not? And $XX to materials million million then ‘hey! provided a like go margin of the to prices quotes provide up, which be you to to quote.’ and we I of Thanks. $XX increased, around a Can possible do quotes in headwind. back more you that freight why the why were is those got sounds there's what that provided, portion or adjust Hi! from of little versus sort Like steel? coming it detail like, versus Inflation just the

So, great question.

inflation. think the half roughly, question, so first is cost freight and costs, going of divided million equally quotes half you that the to should between orders The in to so. flexibility steel half roughly with and on or is customers part So on and backlog, $XX cost of inflation second do to the inflationary of question about there part back the of the second $XX of related million limited is the semiconductor

In does Part us of transitory terms here which can high do semiconductors as you we confidence a costs in inflation see of of customers. come it well. at for that’s or not But focused that customers. also long our in and ’XX the level term, on which the supply pre-buy to gives ’XX a end we’re that, again focused on

now. prices to do a seems that And inflation me Okay, by get that’s cover right, I inflationary that earnings, case prices these maybe your helpful. going for because to it from me like the scenario, guidance Thank ’XX, XXXX mean for assuming are year, like costs the you. then early back one in worst year then could offset pushed

back a maybe So year, worst if not? pushed case is or you that scenario, reasonable get

great your a that’s part think of question. I Yeah

we we’re we outer years those an continue there like that year-over-year your also pricing savings uncertainty working there that in manufacturing executing in productivity, you will with if but given call, strong working pricing earlier then the But or are testing on believe said actions clould, demand. year, basis, services leverage, ongoing incrementally course and have the in these and also the will actions the is the on we cost stick and inflation we of and has already and we're so… So

advanced are advanced stages as the be up will services of the margins leveraged well. gain they aren’t services Many early the Yeah, where leverage as scale. on as as they

much better gross on XXXX we deliver as Yeah. certainly will and XXXX go to scale these So through margins.

squeeze in. just more one can And if Great! I then one

costs, are time in million million, nature in XXXX. them in they being $X the are will one-time those recur what exclude from the one $X For And we mean time of as EBITDA or integration are if they I can million and about in nature adjusted box? them $X think what’s or one kind nature, the

guidance, clear not They we just costs, nature in have have EBITDA to That's and one for we question. that in excluded not our a cost alright. fair are adjusted time those be

XXXX. are a on they drag and EBITDA earnings in So

our integration year. for strategic majority first and we like integrate the in For acquisitions plans to the

So lower. significantly in XXXX is the cost integration

to or So ’XX. think million $X $X about maybe $X million compared million in the

be much. It it's sounds you. temporary a ’XX. overcome in of here thanks will like a that Okay, very Thank sort headwind

comes next the Craig-Hallum from of Matt question Hewitt with Your Capital. line

Your line is open.

Good on I'm side the on A more more seeing sorry the in curious, well? couple about it the afternoon. engrained and and questions. seeing here, you're particularly Thank as trade, for but it of asking that as also semiconductor, you the well, to taking different you about get side up first steel. fronts talked keep maybe the services are inflation, you Peter wage specifically as business,

an Yeah, we question. higher employer able were We to been effective very a talent. believe that's great great who’s

significant haven’t quite we couple As inflation. last have questions, labor of you seen in the seen any

to too good to our it’s do tell. is market. think probably compared early We So compensation

to pandemic, if it little and curious some years doctors and now – I'm as the which it the there. that down, bit was expectation separately, you growth actually start But and the recently to call of then – see that, I'm the be that volumes your and couple is And come has want markets you beneficiary are impacted out with XXXB that, those how curious, of are headwind here is will the know great. down, we procedure maybe of. you'll unless you've a to visits tied of Okay, pandemic, that in through increased like markets all moved into a is this to the patient you over it the CVOID past

in prepared buying my for big to go of of the I X%. think and expect what particularly volumes it slowed hasn't do Many about down we was – sure up, providers we’ve think so that as said I from delayed seen. remarks I but, hospitals really Well,

as for move our So care, there I it healthy think but just toward, is areas. because think also customers I to will be more in the just not through. go outpatient acute volume to And be we more going it's,

Scott’s just about UMC. like So talking

in the so the people that I some So evolved of items they should I think as the done healthcare to in Omicron and moving is pandemic. should increasing. attention the volumes away, many be think say, you have the And as

That's you. Thank helpful.

next Weerasuriya Capital the with Dev Markets. Your of from comes line Berenberg question

Your line open. is

Dev are there? hear you Can us?

me? evening! hear Good Can you Hey! guys

Yeah, we can.

Okay question. for my great. taking Thanks

that. that to So considered want mentioned circle I include this kick million hopefully regards impact. off I it I wage that just wage maybe on confirm, to in there. confirm XXXX inflation guess $XX any inflation inflation out, think just wasn't I just want XXXX on in kind you to doesn't this to it to your of inflation,

Well, we you plan kind million product ’XX? in we always well. good for inflation always Did of [inaudible] $X correspond, we – as say

about Nothing extraordinary, how that.

kind Okay in great. of the just maybe to top And jump then line.

For around and know more kind wanted may just know market. by know SaaS guess that side, example you agreement sell you Where revenue maybe tech you get you some the momentum? have, more easier Omnicell the you ADS. to I One the end color a are services, seeing this of be Sole-Source enabled with On disaggregated maybe

retail or maybe worse You know customers the is payers. new going after

that any disaggregated helpful. on would on more Thank color just So be kind of momentum, the you. side

– I is this Scott. Yeah, think

a the or added strategy so... that home that FDS demand as meds Reset health the business, to that’s the sure and with a of pharmacy. are XXXB, are increasingly Amplicare enterprise. to and mean right those because terms expanding – the help in through the retails Lubbock, I health The other health largely the of and intertwine both comprehensive are locations, solution, is now to from And mean and helping the in and One in systems That’s exclusively vision entire are system when more in more Enliven we we're comprehensive acute. pretty hospitals outpatient think has seeing systems. them the lot ambulatory market not to a that traditional large will focus the hospital actually large hospital and to geographic for not for air the right seeing showing and function those, like But a health always positioned capabilities. home channel real solutions, and the well been that side, grow healthcare. XXXB to that, that would So fill drugs utilize I traffic hospital. of tools to with Things world the effect MarkeTouch outside and inside not then out-patient control Again we certainly the more through linking be certainly we’ve UMC EnlivenHealth in now the certainly retail we driving market, the like systems the start hospital with and even that’s topline, support only look health you management, there’s automate whether that’s portfolio systems at the in demand pharmacy access primary fully is care Omnicell expanding the up (a) business are large at increasingly acute demand but make the beds, that’s I mentioned

example that's Wal-Mart I an maybe taken Okay, EnlivenHealth, on you know example. a is helpful. customer for guess like

recurring regards also edge revenue like side, also on growth margin to here. a and double Just in the question maybe gross

years. are you of interpretation the after revenue on I what on you then to of to And implementation, client. do economic it it per there's would of drivers the side, unit side, guess on would growth improve? expect the guess expect widely? basis kind on gross cost first SaaS kind there some side So roll margin Would be I improve a the couple you out after in a what at that assume rate I

you. side. tech the and advanced on Just services Thank

is its where which around customer. point, First Enliven really an growth for

product, fact, dimensions. to is number number services subscription. stores, – call number So tied what of really then dimension One two one; very and within it two, subscription that are subscription the traditional is that on that

one am I So platform, of then revenue how two customer which any Enliven within into how many many and subscribing am platform stores dimensions, I subscript large adding scale in is would services the right. the

call The comes growth one or of subscription the that that sale And out scheduling services. services, customer of of of platform, so to IVR, etc. the the customer the of on stores the you mentioned the maybe one with rolling really or add one all notion more engaging impact

with market analytics now activity. started some in I maybe want and financial Medicine to and IVR and add I then So price participant ultimately and of payer and scheduling the

really never that, we particular that’s on margin, would it commented a gross a So how can that growth more have Gross dimension. you see scale. margin, like

would generally, customer? over you kind expect margin time it's gross guess I to win of after but Okay, to you a increase

with For you customer add sure, as would volume right, it, the because give cost there’s even to a time at associated SaaS scale business. sure. It a has that more a fixed a

you. Thank great. Okay,

turn call time. closing for the at Randall questions remarks. further no are Lipps I'll There this to back

importantly back time. customers, much. to most and to road. so improve going healthcare joining few you so Hey! over about go I Omnicell that we've gross Thank we'll places in Look everyone and good and the costs. some the some yes, we're see today. get growth and installed always the plan inflationary as for margin there years thank normal everyone, down game so can for we integration get We'll systems costs last mean they the much you been and But us headwinds our are M&A has got the for our you a next

concludes call. This you for you. joining. Thank Thank conference today's

disconnect. now may You